Patents by Inventor Denise Smith

Denise Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of Terlipressin
    Publication number: 20250249066
    Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
    Type: Application
    Filed: November 15, 2024
    Publication date: August 7, 2025
    Inventors: Penelope Markham, Jonathan Adams, Denise Smith, Jorge Bacardit Cabado
  • Formulations of terlipressin
    Patent number: 12156898
    Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: December 3, 2024
    Assignee: BioVie, Inc.
    Inventors: Penelope Markham, Jonathan Adams, Denise Smith, Jorge Bacardit Cabado
  • FORMULATIONS OF TERLIPRESSIN
    Publication number: 20220233634
    Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
    Type: Application
    Filed: May 22, 2020
    Publication date: July 28, 2022
    Inventors: Penelope Markham, Jonathan Adams, Denise Smith, Jorge Bacardit Cabado
  • Formulations of Terlipressin
    Publication number: 20220202907
    Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
    Type: Application
    Filed: March 18, 2022
    Publication date: June 30, 2022
    Inventors: Penelope Markham, Jonathan Adams, Denise Smith, Jorge Bacardit Cabado
  • Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use
    Patent number: 10398785
    Abstract: Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: September 3, 2019
    Assignee: Meridian Lab
    Inventors: William W. Zhao, John K. Thottathil, Denise Smith, Xiaodong Sun, Xiangyu Dong
  • PHARMACEUTICAL COMPOSITIONS CONTAINING TAXANE-CYCLODEXTRIN COMPLEXES, METHOD OF MAKING AND METHODS OF USE
    Publication number: 20180050116
    Abstract: Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.
    Type: Application
    Filed: March 14, 2016
    Publication date: February 22, 2018
    Inventors: William W. Zhao, John K. Thottathil, Denise Smith, Xiaodong Sun, Xiangyu Dong
  • Security certificate management
    Publication number: 20070028095
    Abstract: A system and method for establishing a mutually authenticated secure link between a mobile platform system and a remote system is provided. An onboard computer system (OCS) generates a dynamic certificate and digitally signs the dynamic certificate with a static certificate. The dynamic certificate is transmitted to a remote central computer system (CCS). The CCS verifies that the dynamic certificate is from a trusted source and sends a return dynamic certificate electronically signed with the static certificate to the OCS. The OCS verifies the return dynamic certificate is from the CCS, thereby establishing a mutually authenticated secure link between the OCS and the CCS.
    Type: Application
    Filed: July 28, 2005
    Publication date: February 1, 2007
    Inventors: David Allen, David Savage, Kent Loving, Bruce Pollock, John Cloutier, Denise Smith